Evidence That Insulin is Imprinted in the Human Yolk Sac
Evidence That Insulin is Imprinted in the Human Yolk Sac Gudrun E. Moore , Sayeda N. Abu-Amero , Gill Bell , Emma L. Wakeling , Amanda Kingsnorth , Philip Stanier , Eric Jauniaux and Simon T. Bennett From the Molecular Biology Laboratory for Fetal Development (G.E.M., S.N.A.-A., G.B., E.L.W., P.S.),...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2001-01, Vol.50 (1), p.199-203 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Evidence That Insulin is Imprinted in the Human Yolk Sac
Gudrun E. Moore ,
Sayeda N. Abu-Amero ,
Gill Bell ,
Emma L. Wakeling ,
Amanda Kingsnorth ,
Philip Stanier ,
Eric Jauniaux and
Simon T. Bennett
From the Molecular Biology Laboratory for Fetal Development (G.E.M.,
S.N.A.-A., G.B., E.L.W., P.S.), Division of Paediatrics, Obstetrics and
Gynaecology, Queen Charlotte's and Chelsea Hospital, Imperial College of
Science, Technology and Medicine; the Academic Division of Obstetrics and
Gynaecology (E.J.), Royal Free and University College Medical School,
University College, London; the Department of Medical Genetics (A.K.),
Wellcome Trust Centre of Molecular Mechanisms in Disease, CIMR, University of
Cambridge, Cambridge; and the Oxagen Limited (S.T.B.), Abingdon, Oxon,
U.K.
Address correspondence and reprint requests to Dr. Gudrun Moore, Molecular
Biology Laboratory for Fetal Development, Division of Paediatrics, Obstetrics
and Gynaecology, Queen Charlotte's and Chelsea Hospital, Imperial College of
Science, Technology and Medicine, Goldhawk Rd., London W6 OXG, U.K. E-mail:
gemoore{at}ic.ac.uk
.
Abstract
Allelic variation in the size of the insulin ( INS ) variable number
tandem repeat (VNTR) correlates with the expression of both INS in
the pancreas and thymus and IGF2 (the gene downstream of
INS ) in the placenta. In addition, the shorter, class I alleles are
associated with type 1 diabetes, whereas the longer, class III alleles are
associated with type 2 diabetes, polycystic ovary syndrome (PCOS), and size at
birth. Parent-of-origin effects have been reported for type 2 diabetes and
PCOS, thus implicating a role for genomic imprinting in these phenotypes. In
mice, Ins2 is imprinted and paternally expressed in the yolk sac. In
humans, evidence for the imprinting of INS is circumstantial, with
occasional monoallelic expression in the thymus. In the present study, we
found evidence for the imprinted paternal expression of INS in the
human yolk sac. Two other imprinted genes from the same cluster are also
expressed monoallelically in the human yolk sac. IGF2 was expressed
solely from the paternal allele, and H19 was expressed solely from
the maternal allele. These data suggest not only further functional roles for
the human yolk sac in early fetal growth, but also evidence for a potential
causal link between the control of insulin expression during development and
insulin/growth-related diseases in later life.
Footnotes
PCOS, polycystic ovary syndrome; PCR, p |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.50.1.199 |